Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/1998
11/10/1998US5834489 Continuous epidural infusion, minimal motor blockade, anesthetics
11/10/1998US5834482 Heterocyclic chemistry
11/10/1998US5834478 Morphinan hydroxamic acid compounds
11/10/1998US5834469 Endothelin receptor antagonists
11/10/1998US5834468 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists
11/10/1998US5834463 Condensed heterocyclic compounds, their production and use
11/10/1998US5834238 Human GTP binding protein
11/10/1998US5834188 For inducing human osteogenic protein 1
11/10/1998US5834010 Triacetin as a penetration enhancer for transdermal delivery of a basic drug
11/10/1998CA2073005C Antimuscarinic bronchodilators
11/07/1998CA2231754A1 A novel human g-protein coupled receptor hcept09
11/05/1998WO1998049319A1 Human lysophospholipase
11/05/1998WO1998049308A1 Ngf variants
11/05/1998WO1998049293A1 Human theta subunit of the gaba-a receptor
11/05/1998WO1998049170A1 Spiro-azacyclic derivatives and their use as therapeutic agents
11/05/1998WO1998049168A1 Reverse-turn mimetics and methods relating thereto
11/05/1998WO1998049155A1 Cell differentiation inducing amide derivatives, their production and use
11/05/1998WO1998049145A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/05/1998WO1998049131A1 New benzylamine and phenylethylamine derivatives, processes for preparing the same and their use as medicaments
11/05/1998WO1998048841A1 Use of papovavirus capsid protein for delivery of genetic material
11/05/1998WO1998048821A2 Use of conantokins for producing analgesia or for neuroprotection
11/05/1998WO1998048786A1 AMINOTETRALINS AS 5-HT1Dα AGONISTS
11/05/1998WO1998048785A2 Allelic polygene diagnosis of reward deficiency syndrome and treatment
11/05/1998WO1998048784A2 Method and composition for modulating amyloidosis
11/05/1998WO1998032863A3 Mammalian thioredoxin
11/05/1998WO1998013349A3 Heteroaryloxyethylamines as 5-ht1a ligands
11/05/1998DE19718334A1 Neue Benzylaminderivate und Phenylethylaminderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New benzylamine derivatives and phenylethylamine derivatives, processes for their preparation and their use as medicaments
11/05/1998CA2288990A1 Allelic polygene diagnosis of reward deficiency syndrome and treatment
11/05/1998CA2288897A1 Aminotetralins as 5-ht1d.alpha. agonists
11/05/1998CA2288346A1 Use of conantokins for producing analgesia or for neuroprotection
11/05/1998CA2288308A1 Substituted tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
11/05/1998CA2288073A1 Human lysophospholipase
11/05/1998CA2287782A1 Human theta subunit of the gaba-a receptor
11/05/1998CA2287436A1 Spiro-azacyclic derivatives and their use as therapeutic agents
11/05/1998CA2286558A1 Ngf variants
11/05/1998CA2285948A1 Method and composition for modulating amyloidosis
11/05/1998CA2285402A1 Amide derivatives, their production and use
11/04/1998EP0875577A2 Novel membrane-type matrix metalloproteinase-5 gene
11/04/1998EP0875573A2 CRFG-1b, a target and marker for chronic renal failure
11/04/1998EP0875572A2 CRFG-1a, a target and marker for chronic renal failure
11/04/1998EP0875571A2 CRFG-1, target and marker for chronic renal failure
11/04/1998EP0875568A1 Novel human neurotensin receptor type 2 and splice variants thereof
11/04/1998EP0875566A2 Novel G-protein coupled receptor (HFGAN72X)
11/04/1998EP0875565A2 Novel G-protein coupled receptor (hfgan72y)
11/04/1998EP0875513A1 Substituted heteroaromatic 5-HT 1F agonists
11/04/1998EP0875512A2 New naphthylpiperazine derivatives with antipsychotic activity
11/04/1998EP0874850A1 Novel tricyclic compounds for the inhibition of the ice/ced-3 protease family of enzymes
11/04/1998EP0874849A1 2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives
11/04/1998EP0874847A1 Novel purine derivatives having, in particular, antiproliferative properties, and biological uses thereof
11/04/1998EP0874844A1 Use of heteroaromatic and tricyclic 1,4-dihydro-1,4-dioxo-naphthalene derivatives, resulting novel compounds and therapeutical use thereof
11/04/1998EP0874833A1 4,5-dihydronaphth 1,2-c]isoxazoles and derivatives thereof having cns activity
11/04/1998EP0874820A1 Process for the preparation of optically enriched 4-aryl-3-hydromethyl substituted piperidines to be used as intermediates in the synthesis of paroxetine
11/04/1998EP0874818A1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors
11/04/1998EP0874805A1 Phenylacetamide derivatives
11/04/1998EP0874641A1 Method for effecting changes in the central nervous system by administration of igf-i or igf-ii
11/04/1998EP0874625A1 Indane derivatives for antipsychotic compositions
11/04/1998EP0874621A1 Pharmaceutical compositions
11/04/1998EP0705244B1 Nitrato amino acid disulphides for use in the therapy of disorders of the cardiovasculary system
11/04/1998CN1198158A Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
11/04/1998CN1198097A Stable extract of hypericum perforatum L., process for preparing the same and pharmaceutical compositions
11/04/1998CN1197797A New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
11/04/1998CN1197640A Ankang capsule for abstaining from drugs
11/04/1998CN1040537C Substituted 1,2,4-triazo (1,5-a) pyrimidines its prep. and pharmaceutical composition containing same
11/03/1998US5830998 Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
11/03/1998US5830908 Crystalline hydrochloride of (R)-(-)-2-(N- 4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl-)-butyl!-aminomethyl)-chroman
11/03/1998US5830907 Application of riluzole in the treatment of neurological lesions associated with trauma
11/03/1998US5830906 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
11/03/1998US5830901 Tetrahydropyridinylmethyl derivatives of pyrrolo 2,3-B!pyridine
11/03/1998US5830896 Psychological disorders; antiepilepic agents; alzheimer'sand parkinson?s disease
11/03/1998US5830892 Piperidine and morphonline derivatives and their use as therapeutic agents
11/03/1998US5830880 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
11/03/1998US5830858 Neurotrophic factor
11/03/1998US5830705 Procaryotic or eukaryotic exoression of an exogenous dna sequence
11/03/1998US5830671 Method for assaying for modulators of cytokines of the TFG β superfamily
11/03/1998US5830460 Immunosuppressant
11/03/1998CA2131789C Biologically active tropane derivatives
11/03/1998CA2058443C Treating disorders by application of insulin-like growth factors and analogs
11/03/1998CA1340113C Aryl-and heteroaryl piperazinyl carboxamides having central nervous system activity
11/01/1998CA2236128A1 Novel compounds
10/1998
10/30/1998CA2236248A1 Crfg-1a, a target and marker for chronic renal failure
10/30/1998CA2231748A1 Novel g-protein coupled receptor (hfgan72x)
10/30/1998CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/30/1998CA2228742A1 Crfg-1, a target and marker for chronic renal failure
10/30/1998CA2228736A1 Crfg-1b, a target and marker for chronic renal failure
10/29/1998WO1998048018A1 Recombinant human beta interferon with enhanced solubility
10/29/1998WO1998047917A2 A PURIFIED 20 kDa PRESENILIN 2 C-TERMINAL FRAGMENT AND METHODS OF SCREENING FOR COMPOUNDS THAT INHIBIT PROTEOLYSIS OF PRESENILIN 2
10/29/1998WO1998047903A1 Crf antagonistic thiophenopyridines
10/29/1998WO1998047902A1 9,10-diazatricyclo[4.2.1.12,5]decane and 9,10-diazatricyclo[3.3.1.12,6]decane derivatives having analgesic activity
10/29/1998WO1998047900A1 Heterocyclic compounds and their preparation and use
10/29/1998WO1998047898A1 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/29/1998WO1998047885A1 A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity
10/29/1998WO1998047874A1 Crf antagonistic quino- and quinazolines
10/29/1998WO1998047872A1 Process for preparing pure flupirtin maleate and its modification a
10/29/1998WO1998047869A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/29/1998WO1998047506A1 Gastric-retained pharmaceutical composition
10/29/1998WO1998047502A1 IBUPROFEN THIOESTERS AS INHIBITORS OF Nf-λB-DEPENDENT PAIN AND INFLAMMATION MEDIATOR FORMATION
10/29/1998WO1998047498A1 Neuroprotective compounds and uses thereof
10/29/1998WO1998041629A3 Death domain containing receptor 5
10/29/1998WO1998041538A3 Novel human cytokine/steroid receptor protein
10/29/1998DE19717864A1 Humanes rekombinantes Interferon-beta mit verbesserter Löslichkeit Human recombinant interferon-beta with improved solubility
1 ... 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 1594 1595 ... 1833